Evidence map›Paper›PMID 40413672›Full record

ReviewDiscover oncology2025

Reciprocal regulation between m6 A modifications and non-coding RNAs: emerging roles in cancer therapeutic resistance.

Dan Fan, Yan Shang, Yating Cong, Yanlin Jiao, Na Li, Hailong Zhao

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dan FanNanshan Class, The First Clinical Institute, Zunyi Medical University, Zunyi, 563000, China.
Yan ShangDepartment of Pathophysiology, Zunyi Medical University, Zunyi, 563000, China.
Yating CongDepartment of Pathophysiology, Zunyi Medical University, Zunyi, 563000, China.
Yanlin JiaoDepartment of Pathophysiology, Zunyi Medical University, Zunyi, 563000, China.
Na LiThe First Clinical Institute, Zunyi Medical University, Zunyi, 563000, China.
Hailong ZhaoDepartment of Pathophysiology, Zunyi Medical University, Zunyi, 563000, China. hailongzhao@zmu.edu.cn.

Funding

the College Students' Innovation and Entrepreneurship Training Program Project of Zunyi Medical University S202310661178the National Natural Science Foundation of China 82060503the Project of the Guizhou Provincial Department of Science and Technology QKH-JC-ZK-2022-622
6 · The paper itself

Abstract

In recent years, the interplay between N6-methyladenosine (m

Indexed as

Cancer therapeutic resistanceM6 A modificationsNon-coding RNAReciprocal regulation

Identifiers

PMID40413672
PMCPMC12104133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.